Glucagon-like peptide 1 receptor agonists appear to reduce the risk of age-related macular degeneration and primary open-angle glaucoma.

GLP-1 RA use linked to lower risks for myelodysplastic syndromes, myeloproliferative neoplasms compared with metformin ...

Anti-obesity drugs are only part of the larger treatment plan for most patients. Exercise and nutrition are also keys.

Popular weight-loss drugs like Ozempic (generic name: semaglutide), which are intended for people with type 2 diabetes and also known as GLP-1 agonist drugs, may be beneficial for brain health, but ...

For patients with type 2 diabetes (T2D), glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with a reduced risk for developing hematologic cancers compared with insulin and ...

The clinician then assesses whether you’re a candidate for prescription weight loss medications, including GLP-1 agonists. These medications work by reducing your appetite, slowing the emptying ...

Every gummy on the market contains a different blend of ingredients, but common ingredients include apple cider vinegar (ACV), B vitamins, and now, a compounded form of semaglutide (a GLP-1 agonist ..

THURSDAY, March 6, 2025 (HealthDay News) -- Preoperative glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is not associated with short-term postoperative aspiration pneumonia, according to a ...

THURSDAY, March 6, 2025 (HealthDay News) -- GLP-1 drugs like Ozempic can help kidney transplant patients avoid organ failure and live longer, a new study suggests. The drugs help manage patients ...